Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more
Enzo Biochem Inc (ENZ) - Total Assets
Latest total assets as of April 2025: $63.52 Million USD
Based on the latest financial reports, Enzo Biochem Inc (ENZ) holds total assets worth $63.52 Million USD as of April 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Enzo Biochem Inc - Total Assets Trend (1986–2024)
This chart illustrates how Enzo Biochem Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Enzo Biochem Inc - Asset Composition Analysis
Current Asset Composition (July 2024)
Enzo Biochem Inc's total assets of $63.52 Million consist of 81.7% current assets and 18.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 61.1% |
| Accounts Receivable | $3.99 Million | 4.7% |
| Inventory | $6.83 Million | 8.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1986–2024)
This chart illustrates how Enzo Biochem Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Enzo Biochem Inc's current assets represent 81.7% of total assets in 2024, an increase from 74.9% in 1986.
- Cash Position: Cash and equivalents constituted 61.1% of total assets in 2024, down from 70.4% in 1986.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 1986.
- Asset Diversification: The largest asset category is inventory at 8.0% of total assets.
Enzo Biochem Inc Competitors by Total Assets
Key competitors of Enzo Biochem Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Enzo Biochem Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Enzo Biochem Inc generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Enzo Biochem Inc is currently not profitable relative to its asset base.
Enzo Biochem Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.84 | 3.50 | 2.10 |
| Quick Ratio | 2.50 | 3.16 | 1.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $31.27 Million | $ 54.07 Million | $ 35.96 Million |
Enzo Biochem Inc - Advanced Valuation Insights
This section examines the relationship between Enzo Biochem Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.65 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -29.6% |
| Total Assets | $85.76 Million |
| Market Capitalization | $16.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Enzo Biochem Inc's assets below their book value (0.19 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Enzo Biochem Inc's assets decreased by 29.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Enzo Biochem Inc (1986–2024)
The table below shows the annual total assets of Enzo Biochem Inc from 1986 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-07-31 | $85.76 Million | -29.63% |
| 2023-07-31 | $121.88 Million | +27.15% |
| 2022-07-31 | $95.86 Million | -15.69% |
| 2021-07-31 | $113.69 Million | +1.02% |
| 2020-07-31 | $112.54 Million | +5.53% |
| 2019-07-31 | $106.64 Million | +4.90% |
| 2018-07-31 | $101.66 Million | -5.58% |
| 2017-07-31 | $107.67 Million | -3.72% |
| 2016-07-31 | $111.82 Million | +63.50% |
| 2015-07-31 | $68.39 Million | +6.18% |
| 2014-07-31 | $64.41 Million | +9.25% |
| 2013-07-31 | $58.96 Million | -14.71% |
| 2012-07-31 | $69.12 Million | -36.86% |
| 2011-07-31 | $109.47 Million | -5.01% |
| 2010-07-31 | $115.25 Million | -13.43% |
| 2009-07-31 | $133.13 Million | -13.85% |
| 2008-07-31 | $154.52 Million | -2.82% |
| 2007-07-31 | $159.00 Million | +56.62% |
| 2006-07-31 | $101.52 Million | -12.83% |
| 2005-07-31 | $116.47 Million | +5.56% |
| 2004-07-31 | $110.33 Million | -4.78% |
| 2003-07-31 | $115.88 Million | +6.03% |
| 2002-07-31 | $109.29 Million | +6.18% |
| 2001-07-31 | $102.93 Million | +11.54% |
| 2000-07-31 | $92.29 Million | +16.96% |
| 1999-07-31 | $78.90 Million | +9.28% |
| 1998-07-31 | $72.20 Million | +7.12% |
| 1997-07-31 | $67.40 Million | +7.32% |
| 1996-07-31 | $62.80 Million | -13.38% |
| 1995-07-31 | $72.50 Million | +11.54% |
| 1994-07-31 | $65.00 Million | +36.55% |
| 1993-07-31 | $47.60 Million | -4.42% |
| 1992-07-31 | $49.80 Million | +1.01% |
| 1991-07-31 | $49.30 Million | -25.86% |
| 1990-07-31 | $66.50 Million | -10.86% |
| 1989-07-31 | $74.60 Million | +6.72% |
| 1988-07-31 | $69.90 Million | -7.66% |
| 1987-07-31 | $75.70 Million | +0.53% |
| 1986-07-31 | $75.30 Million | -- |